Identification of calcium, sodium, magnesium and chloride ion levels in hypertensive and non-hypertensive trinidadians.

Hypertension is a progressive cardiovascular disease with association to risk factors. These risk factors in conjunction with essential elements has become identifiable with the development of the progressive disease. The key purpose of this investigation was to identify the levels of the essential elements, Sodium (Na+), Magnesium (Mg2+), Chloride (Cl-) and Calcium (Ca2+) in both hypertensive and non-hypertensive patients in a Trinidadian population. To achieve this objective a case-control investigation was conducted in which both hypertensive and non-hypertensive patients were assessed. Patients were issued a questionnaire with a series of open-ended questions related to the study. Blood was then drawn from each patient once consent was obtained and sent to the lab to be assayed for the elements. Fifty hypertensive (50) patients were compared with 50 non-hypertensive patients. The average levels obtained for Na+, Cl-, Ca2+ and Mg2+ were 162.08±4.27 mmol/dL (P=0.53), 120.1±58.31 mmol/dL (P=0.51), 2.78±0.86 mmol/dL (P=0.47) and 0.52±0.31 mmol/dL (P<0.001) respectively for the hypertensive patients. The results in the present study revealed higher levels of Na+, Ca2+ and Cl- and lower levels of Mg2+ in the hypertensive patients. The hypertensive patients were also identifiable with having high cholesterol, type 2 diabetes, and cardiovascular conditions. Sixty-two (62%) of the hypertensive patients lived with the condition for more than 10 years. The results obtained for the Trinidadian population revealed in conclusion that hypertensive patients have higher levels of Na+, Ca2+ and Cl- and lower levels of Mg2+. These results are similar to the global results with small differences in their average level of each ion identified.

Application of a novel sex independent anthropometric index, termed angle index, in relation to type 2 diabetes: a Trinidadian case-control study.

OBJECTIVE: To develop a novel sex independent anthropometric index, termed as angle index, related to type 2 diabetes. DESIGN: Case-control. PARTICIPANTS: The study comprised 121 participants and were divided into two groups. One group had no form of diabetes and served as controls (n=50). The other group had the condition of type 2 diabetes (n=71). 31% (n=37) of the subjects were male and 69% (n=84) were female. 62% (n=75) of the subjects were of East Indian ethnicity, 28% (n=34) were of African ethnicity and 10% (n=12) were of mixed ethnicity. SETTING: Participants of the study were from the island of Trinidad, located in the Caribbean. Patients in the study were selected at random from hospital records. PRIMARY OUTCOME MEASURE: It was hypothesised that the mean angle index of patients with type 2 diabetes would be higher than the mean angle index of patients without type 2 diabetes. RESULTS: Patients with type 2 diabetes had a significantly higher angle index value as compared with controls (p<0.001). Angle index was the superior sex independent anthropometric index in relation to type 2 diabetes (area under the curve=0.72; p<0.001) as compared with other sex independent variables. Angle index correlated with glycated haemoglobin (rs=0.28, p=0.003) and fasting blood glucose (rs=0.31, p=0.001) levels. Patients with type 2 diabetes were four times more likely to have an angle index greater than 184° (OR 4.2, 95% CI 1.8 to 9.9) as compared with controls. CONCLUSION: Angle index was a superior sex independent index for discriminating between patients with and without type 2 diabetes, as compared with waist circumference, abdominal volume index, conicity index, blood pressure readings, triglyceride levels and very low-density lipoprotein levels.

Evaluation of vitamin D relationship with type 2 diabetes and systolic blood pressure.

OBJECTIVE: To investigate whether relationships exist among vitamin D, type 2 diabetes mellitus (T2DM), and blood pressure in Trinidadian subjects with T2DM. RESEARCH DESIGN AND METHODS: This was a case-controlled study to determine if vitamin D levels were lower in patients with T2DM. After data analysis, an exploratory hypothesis of vitamin D relationship to systolic blood pressure (SBP) was developed. Plasma calcifediol (25(OH)D) concentrations were used as a measurement for vitamin D levels and were determined by ELISA. Cholesterol levels were measured by an automated dry chemistry analyzer and blood pressure was measured using an automatic blood pressure monitor. RESULTS: There was no significant difference (p=0.139, n=76) in 25(OH)D levels between patients with T2DM and controls. Subjects with SBP above 130 mm Hg were 8 times more likely to have a 25(OH)D plasma concentration above 25 ng/mL (OR 7.9 (2.2 to 28.7)), and were 5 times (OR 4.7 (1.7 to 15.1)) more likely to have a 25(OH)D plasma concentration above 30 ng/mL (OR 7.5 (2.3-24.2)). Vitamin D levels moderately and positively correlated with SBP (rs=0.38, p=0.001). CONCLUSIONS: There was no significant difference in the 25(OH)D levels between patients with T2DM and controls (p=0.139). Patients with SBP under 130 mm Hg were 8 times more likely to have a vitamin D level above 25 ng/mL (OR 7.9 (2.2 to 28.7)). Further investigations are required to examine the relationship between vitamin D and SBP.